Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
DYN
DYN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DYN News
Dyne Therapeutics Expands Debt Facility to $400M with Hercules Capital
3d ago
seekingalpha
Dyne Therapeutics Secures $125 Million in Additional Financing
3d ago
Newsfilter
Dyne Therapeutics Completes Enrollment in DM1 Trial Expansion Cohort
Jun 03 2026
Newsfilter
FCPM III Services B.V. Reduces Stake in Dyne Therapeutics
May 30 2026
Fool
FCPM III Reduces Stake in Dyne Therapeutics by $14 Million
May 30 2026
Yahoo Finance
Dyne Therapeutics Submits BLA for DMD Treatment Z-rostudirsen
May 27 2026
NASDAQ.COM
Dyne Therapeutics Submits BLA for Accelerated Approval of z-rostudirsen
May 26 2026
Newsfilter
Dyne Therapeutics Grants Inducement Equity Awards to New Employees
May 20 2026
Newsfilter
Dyne Therapeutics Initiates Late-Stage DMD Trial for z-rostudirsen
May 20 2026
stocktwits
Dyne Therapeutics Launches Late-Stage Trial for DMD Therapy
May 20 2026
seekingalpha
Saturn V Capital Management Sells Dyne Therapeutics Shares
May 19 2026
Fool
Saturn V Sells Dyne Therapeutics Shares Worth $14.17 Million
May 19 2026
NASDAQ.COM
Dyne Therapeutics Reports Positive FDA Meeting Progress
May 11 2026
Newsfilter
Dyne Therapeutics Presents New Data on FORCE Platform's CNS Delivery
Apr 27 2026
Newsfilter
Dyne Therapeutics Presents Clinical Trial Posters on DMD and DM1 at AMCP 2026
Apr 01 2026
Newsfilter
Dyne Therapeutics Shares Surge 11.81% on Buy Rating
Mar 11 2026
Yahoo Finance
Show More News
